Industrial R&D paradigm shift to vaccines.

Krishan Maggon, R&D Paradigm Shift and Billion‐Dollar Biologics Pharmaceutical Sciences Encyclopedia. pp. 161- 199 ,(2010) , 10.1002/9780470571224.PSE294

Daniel C. Payne, Laura H. Franzke, Paul A. Stehr-Green, Benjamin Schwartz, Michael M. McNeil, Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbed. Pharmacoepidemiology and Drug Safety. ,vol. 16, pp. 46- 54 ,(2007) , 10.1002/PDS.1213

Simone Mocellin, Donato Nitti, Therapeutics targeting tumor immune escape: Towards the development of new generation anticancer vaccines Medicinal Research Reviews. ,vol. 28, pp. 413- 444 ,(2008) , 10.1002/MED.20110

Julia Romanova, The fight against new types of influenza virus Biotechnology Journal. ,vol. 1, pp. 1381- 1392 ,(2006) , 10.1002/BIOT.200600159

Heather E. Hsu, Kathleen A. Shutt, Matthew R. Moore, Bernard W. Beall, Nancy M. Bennett, Allen S. Craig, Monica M. Farley, James H. Jorgensen, Catherine A. Lexau, Susan Petit, Arthur Reingold, William Schaffner, Ann Thomas, Cynthia G. Whitney, Lee H. Harrison, Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis The New England Journal of Medicine. ,vol. 360, pp. 244- 256 ,(2009) , 10.1056/NEJMOA0800836